Spectrum Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (32)

Latest Posts

About This Stock More About This Stock
Week In Review: China Pharmas Announce Deals Worth $1.5 Billion
Article By: ChinaBio® Today
Saturday, December 8, 2018 4:21 PM EST
WuXi AppTec, China's largest CRO/CMO, completed a $1 billion IPO on the Hong Kong markets, pricing the offering in the middle of the expected range (see story). In May, WuXi became a public company by completing a $328 million IPO in Shanghai.
In this article: RVNC, VBIV, CASI, SPPI
Read
Spectrum (SPPI) Earnings And Sales Beat Estimates In Q1
Article By: Zacks Investment Research
Saturday, May 5, 2018 9:05 PM EST
Spectrum Pharma’s shares have underperformed the industry so far this year. The stock has lost 16.5% against the industry’s decline of 5%. Plus more news on Amgen, Ligand Pharmaceuticals and Protagonist Therapeutics.
In this article: SPPI, AMGN, LGND, PTGX
Read
The World’s Most Expensive Drug ($1,210,000/dose) From UniQure B.V. Will Soon Become Extinct
Article By: Lorimer Wilson
Thursday, April 20, 2017 11:24 AM EST
The world’s most expensive drug, from UniQure,. will soon become extinct. Here is a list of the top 10; #10 on the list still costs $450,540.
In this article: SPPI, QURE Also: SNY, ALXN, BMRN, HZNP, BIVV
Read
3 Drug Stocks That Could Benefit From Key FDA Events In Sep. 2016
Article By: Arpita Dutt
Monday, September 12, 2016 1:25 PM EST
The drug development process is often lengthy and time-consuming and requires the utilization of a lot of funds and resources. It may well take a drug anything between 10-12 years to be successfully developed and reach the market.
In this article: VRTX, AMGN, SPPI Also: ABBV
Read
Week In Review: 3SBio Acquires Wansheng Pharma For $85 Million
Article By: ChinaBio® Today
Saturday, July 25, 2015 3:00 PM EST
3SBio of Shenyang acquired Zhejiang Wansheng Pharma, a small molecule drugmaker, for $85 million. Wansheng is approved to market 55 products in the areas of oncology, diabetes, cardiovascular and dermatology.
In this article: CASI, CRME, SPPI
Read

PARTNER HEADLINES

Latest Tweets for $SPPI

No tweets yet!